Incyte SG&A decreased by 16.0% to $328.09M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $325.69M to $328.09M. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 16.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $168.86M | $190.70M | $226.20M | $209.58M | $253.28M | $266.46M | $272.82M | $315.61M | $283.93M | $267.89M | $288.23M | $300.26M | $305.98M | $309.21M | $326.71M | $325.69M | $331.02M | $329.08M | $390.41M | $328.09M |
| QoQ Change | — | +12.9% | +18.6% | -7.3% | +20.8% | +5.2% | +2.4% | +15.7% | -10.0% | -5.6% | +7.6% | +4.2% | +1.9% | +1.1% | +5.7% | -0.3% | +1.6% | -0.6% | +18.6% | -16.0% |
| YoY Change | — | — | — | — | +50.0% | +39.7% | +20.6% | +50.6% | +12.1% | +0.5% | +5.7% | -4.9% | +7.8% | +15.4% | +13.3% | +8.5% | +8.2% | +6.4% | +19.5% | +0.7% |